pomalidomide

Ukraine

Drugs containing this active substance

  • AMPOMAY

    The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with bortezomib and dexamethasone or with dexamethasone alone, depending on the patient's previous treatment experience.

    Form: capsules

    Active substance Dosage
    pomalidomide 1 mg

    ATC: L04AX06

    Manufacturer: Hetero Labs Limited

  • AMPOMAY

    The drug is intended for the treatment of adult patients with multiple myeloma. It is used either in combination with bortezomib and dexamethasone, or in combination with dexamethasone (depending on the patient's previous treatment experience).

    Form: capsules

    Active substance Dosage
    pomalidomide 2 mg

    ATC: L04AX06

    Manufacturer: Hetero Labs Limited

  • AMPOMAY

    The drug is intended for the treatment of adult patients with multiple myeloma. It is used either in combination with bortezomib and dexamethasone, or with dexamethasone alone, depending on the patient's previous treatment experience.

    Form: capsules

    Active substance Dosage
    pomalidomide 3 mg

    ATC: L04AX06

    Manufacturer: Hetero Labs Limited

  • AMPOMAY

    The drug is intended for the treatment of adult patients with multiple myeloma. It is used either in combination with bortezomib and dexamethasone, or in combination with dexamethasone, depending on the patient's previous treatment experience.

    Form: capsules

    Active substance Dosage
    pomalidomide 4 mg

    ATC: L04AX06

    Manufacturer: Hetero Labs Limited

  • POMALID

    The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with bortezomib and dexamethasone or with dexamethasone alone, depending on the patient's previous treatment history.

    Form: capsules, hard

    Active substance Dosage
    pomalidomide 2 mg

    ATC: L04AX06

    Manufacturer: Nacto Pharma Limited

  • POMALID

    The drug is prescribed to adults for the treatment of multiple myeloma. It is used in combination with other medicinal products (bortezomib and dexamethasone or dexamethasone alone) depending on the patient's previous treatment experience.

    Form: capsules, hard

    Active substance Dosage
    pomalidomide 3 mg

    ATC: L04AX06

    Manufacturer: Nacto Pharma Limited

  • POMALID

    The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with bortezomib and dexamethasone or with dexamethasone alone, depending on the patient's previous treatment experience with other drugs (including lenalidomide).

    Form: capsules, hard

    Active substance Dosage
    pomalidomide 4 mg

    ATC: L04AX06

    Manufacturer: Nacto Pharma Limited

  • POMALIDOMIDE-VISTA

    The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with other medicinal products (bortezomib and dexamethasone or dexamethasone alone) depending on the patient's previous treatment experience.

    Form: capsules, hard

    Active substance Dosage
    pomalidomide 2 mg

    ATC: L04AX06

    Manufacturer: Synthon Hispania, S.L. (manufacturing (full cycle))

  • POMALIDOMIDE-VISTA

    The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with other medicinal products (bortezomib and dexamethasone or dexamethasone alone) depending on the patient's previous therapy.

    Form: capsules, hard

    Active substance Dosage
    pomalidomide 3 mg

    ATC: L04AX06

    Manufacturer: Synthon Hispania, S.L. (manufacturing (full cycle))

  • POMALIDOMIDE-VISTA

    The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with other medicinal products (bortezomib and dexamethasone or dexamethasone alone) depending on the patient's previous therapy.

    Form: capsules, hard

    Active substance Dosage
    pomalidomide 4 mg

    ATC: L04AX06

    Manufacturer: Synthon Hispania, S.L. (manufacturing (full cycle))

  • XENPOMA

    The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with other medicinal products (bortezomib and dexamethasone or dexamethasone alone) depending on the patient's previous treatment experience.

    Form: capsules, hard

    Active substance Dosage
    pomalidomide 1 mg

    ATC: L04AX06

    Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7

  • XENPOMA

    The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with other medicinal products (bortezomib and dexamethasone or dexamethasone alone) depending on the patient's previous treatment experience.

    Form: capsules, hard

    Active substance Dosage
    pomalidomide 2 mg

    ATC: L04AX06

    Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7

  • XENPOMA

    The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with other medicinal products (bortezomib and dexamethasone or dexamethasone alone) depending on the patient's previous treatment experience.

    Form: capsules, hard

    Active substance Dosage
    pomalidomide 3 mg

    ATC: L04AX06

    Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7

  • XENPOMA

    The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with other medicinal products (bortezomib and dexamethasone or dexamethasone alone) depending on the patient's previous treatment history.

    Form: capsules, hard

    Active substance Dosage
    pomalidomide 4 mg

    ATC: L04AX06

    Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7